What did Novo Nordisk pay for BIOCORP Production SA?

Novo Nordisk acquired BIOCORP Production SA for $164.0M in 2023, equivalent to 12.70x revenue. Target revenue was approximately $12.9M.

What does BIOCORP Production SA do?

BIOCORP Production SA is a medical devices business.

What multiple did Novo Nordisk pay for BIOCORP Production SA?

12.70x revenue, based on disclosed deal value of $164.0M and disclosed financials.

M&A TRANSACTION · 2023

BIOCORP Production SA acquired by Novo Nordisk

$164.0M· 12.70x revenue

Target

BIOCORP Production SA

Acquirer

Novo Nordisk

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$12.9M

EBITDA

—

Deal Value

$164.0M

EV/EBITDA

—

Context

This $164.0M acquisition of BIOCORP Production SA by Novo Nordisk sits in the medical devices sub-vertical. Novo Nordisk is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the BIOCORP Production SA acquisition.

Citation: ExitValue.ai. (2023). BIOCORP Production SA acquired by Novo Nordisk. https://exitvalue.ai/deals/biocorp-production-sa-acquired-by-novo-nordisk-hc-2023-0046